Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -364.24% is 67% above its 5-year average of -1091.43%, near the high end of its 5-year range (-5666.23%–-97.52%).
59.77% above its 12-month average of -905.38%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -703.46%.
OPERATING MARGIN
-364.24%
OPERATING MARGIN AVG TTM
-905.38%
OPERATING MARGIN AVG 3Y
-678.54%
OPERATING MARGIN AVG 5Y
-1091.43%
OPERATING MARGIN AVG 10Y
-1128.78%
OPERATING MARGIN AVG 15Y
-811.96%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+59.77%
CURRENT VS 3Y AVG
+46.32%
CURRENT VS 5Y AVG
+66.63%
CURRENT VS 10Y AVG
+67.73%
CURRENT VS 15Y AVG
+55.14%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Evogene Ltd.
Market Cap
$3.65M
Operating Margin
-364.24%
TTM Avg
-905.38%
3Y Avg
-678.54%
5Y Avg
-1091.43%
Market Cap
$3.65M
Operating Margin
0.00%
TTM Avg
-1346.57%
3Y Avg
-8443.50%
5Y Avg
-5629.00%
Market Cap
$3.63M
Operating Margin
-25.34%
TTM Avg
-25.34%
3Y Avg
-17.96%
5Y Avg
-5.58%
Market Cap
$3.53M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.50M
Operating Margin
-3.14%
TTM Avg
-81.95%
3Y Avg
-224.77%
5Y Avg
-179.82%
Market Cap
$3.90M
Operating Margin
-774.90%
TTM Avg
-1185.31%
3Y Avg
-1296.90%
5Y Avg
-883.94%
Market Cap
$3.93M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-229.94%
5Y Avg
-288.65%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Evogene Ltd. (EVGN) | $3.65M | -364.24% | -905.38% | -678.54% | -1091.43% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.65M | 0.00% | -1346.57% | -8443.50% | -5629.00% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.63M | -25.34% | -25.34% | -17.96% | -5.58% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.53M | 0.00% | 0.00% | 0.00% | 0.00% |
| Moolec Science S.A. (MLEC)vs › | $3.50M | -3.14% | -81.95% | -224.77% | -179.82% |
| Eocene Ltd. (EOCN)vs › | $3.50M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | 0.00% | 0.00% | 0.00% | 0.00% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -774.90% | -1185.31% | -1296.90% | -883.94% |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.93M | 0.00% | 0.00% | -229.94% | -288.65% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | -2781.69% | -3688.91% | -3165.01% | -3029.85% |
Gross Margin
-6.3%
Operating Margin
-364.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -703.46% |
| 2026-03-31 | -943.11% |
| 2025-12-31 | -1659.87% |
| 2025-09-30 | -873.08% |
| 2025-06-30 | -347.40% |
| 2025-03-31 | -168.82% |
| 2024-12-31 | -283.49% |
| 2024-09-30 | -340.23% |
| 2024-06-30 | -765.12% |
| 2024-03-31 | -97.52% |
| 2023-12-31 | -1319.72% |
| 2023-09-30 | -111.04% |
| 2023-06-30 | -1208.10% |
| 2023-03-31 | -1060.22% |
| 2022-12-31 | -573.03% |
| 2022-09-30 | -1522.96% |
| 2022-06-30 | -2566.35% |
| 2022-03-31 | -3398.73% |
| 2021-12-31 | -2794.86% |
| 2021-09-30 | -5666.23% |
| 2021-06-30 | -5515.56% |
| 2021-03-31 | -1879.58% |
| 2020-12-31 | -2044.73% |
| 2020-09-30 | -1757.28% |
| 2020-06-30 | -1753.69% |
| 2020-03-31 | -9144.00% |
| 2019-12-31 | -5931.90% |
| 2019-09-30 | -5064.95% |
| 2019-06-30 | -2449.48% |
| 2019-03-31 | -1341.67% |
| 2018-12-31 | -829.45% |
| 2018-09-30 | -1390.46% |
| 2018-06-30 | -1232.98% |
| 2018-03-31 | -1351.37% |
| 2017-12-31 | -820.03% |
| 2017-09-30 | -735.56% |
| 2017-06-30 | -438.62% |
| 2017-03-31 | -729.40% |
| 2016-12-31 | -521.36% |
| 2016-09-30 | -336.72% |
| 2016-06-30 | -286.56% |
| 2016-03-31 | -227.38% |
| 2015-12-31 | -217.99% |
| 2015-09-30 | -114.29% |
| 2015-06-30 | -174.77% |
| 2015-03-31 | -152.83% |
| 2014-12-31 | -126.29% |
| 2014-09-30 | -136.09% |
| 2014-06-30 | -96.83% |
| 2014-03-31 | -68.06% |
| 2013-12-31 | -91.64% |
| 2013-09-30 | -59.71% |
| 2013-06-30 | -36.29% |
| 2013-03-31 | -12.61% |
| 2012-12-31 | -19.10% |
| 2012-09-30 | -27.45% |
| 2012-06-30 | -24.37% |
